Company Overview
Snapshot
Founded in January 2011 by Gershon Goldenberg, InjecTec operates with 1–10 employees. The company's product, MultiTox, is a patent-pending cradle designed for precise botulinum toxin injections. InjecTec ceased operations in March 2017.
Business overview
InjecTec develops medical devices for the healthcare and cosmetics industries, specifically focusing on solutions for botulinum toxin injections. Its core product, MultiTox, is an innovative syringe cradle designed to ensure accuracy, precise placement, and exact dosage during multi-use injections. This technology aims to improve the precision of medical and cosmetic procedures for providers in the healthcare sector.
Log in to access full profile ›Company Intelligence Q&A
- What is InjecTec's primary product?
- InjecTec's primary product is MultiTox, a patent-pending cradle designed for multi-use botulinum toxin injections, facilitating precise dosage and placement.
- When was InjecTec founded?
- InjecTec was founded in January 2011.
- Who is the founder of InjecTec?
- Gershon Goldenberg is the founder of InjecTec.
- What is the operational status of InjecTec?
- InjecTec is currently non-active, having ceased operations in March 2017.
- What industries does InjecTec serve?
- InjecTec serves the healthcare and life sciences industries, with a focus on providers in the medical and cosmetics sectors.